Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility
ConclusionsThese data indicate targeting EBV may be of therapeutic benefit in MS.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research